This page indexes the U.S. FDA drug recalls that the agency has classified as
Class III. It is a regulatory finding aid, not medical advice.
What "Class III" means as a regulatory classification
Class III is the least serious of the three classifications the FDA uses for drug recalls in its
enforcement reports. As with the other tiers, it is the agency's categorisation of the recall
event within its regulatory framework: assigned by the FDA, recorded as a field in the
report, and reproduced here precisely as the source states it. The label is administrative only.
It is not a personalised risk score, not a clinical judgement, and not guidance about how any
individual should act.
Class III is typically applied to recalls of a more administrative character. For teams tracking
the enforcement stream, the Class III view is useful for completeness — it rounds out the picture
of recall activity beyond the higher-priority tiers and can surface patterns in routine
labelling or packaging corrections. The purpose of indexing these records here is the same as
for every tier: to make them quick to find, date and cross-reference, with a direct link back to
the verifiable openFDA source for the official report.
How to read the Class III list
The table below lists the Class III recall records currently in the indexed dataset, newest
first by report date. Each row links to a dedicated record page that presents the product
description, recalling firm, the firm's stated reason, the distribution pattern, the geographic
fields and the dates — all as regulatory data points from the enforcement report — and links on
to the official openFDA source.
The standard cautions apply. A Class III entry records a regulatory action and is an
administrative fact, not a clinical warning, and it implies nothing about risk to a particular
person. The list reflects the data as of the most recent ingestion, which can lag the live FDA
record, so verify the current status against the official source.
Each Class III record page presents the same regulatory fields from the FDA enforcement report:
the recall number and event identifier that tie the entry to the agency's systems, the product
description as characterised by the firm, the recalling firm that conducted the action, the firm's
verbatim stated reason as a data field, the distribution pattern, the state and country fields,
and the report, initiation and termination dates. Reproducing these consistently makes the
least-serious tier as easy to scan and verify as the others, which matters for teams that want a
complete picture of enforcement activity rather than only the higher-priority actions.
As with every tier, the structure here is organisational rather than interpretive. A Class III
entry is an administrative record of a regulatory action; it carries no clinical meaning, no
assessment of risk to any person, and no recommendation. The classification and the field values
are the FDA's, and the purpose of the page is solely to surface them clearly and link back to the
authoritative source for verification.